KR890007741A - 진통제 - Google Patents

진통제 Download PDF

Info

Publication number
KR890007741A
KR890007741A KR1019880014833A KR880014833A KR890007741A KR 890007741 A KR890007741 A KR 890007741A KR 1019880014833 A KR1019880014833 A KR 1019880014833A KR 880014833 A KR880014833 A KR 880014833A KR 890007741 A KR890007741 A KR 890007741A
Authority
KR
South Korea
Prior art keywords
alkoxy
alkyl
formula
physiologically acceptable
alkylthio
Prior art date
Application number
KR1019880014833A
Other languages
English (en)
Inventor
라다쯔 페터
베버 볼프-디이트리히
바버 앤드류
볼프 한스-페터
제이프리트 크리스토프
Original Assignee
나우만, 호이만
메르크 파텐트 게젤샤프트 미트 배슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나우만, 호이만, 메르크 파텐트 게젤샤프트 미트 배슈랭크터 하프퉁 filed Critical 나우만, 호이만
Publication of KR890007741A publication Critical patent/KR890007741A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

진통제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 다음 일반식(I)의 피리미딘 유도체 및/또는 이의 생리학적으로 허용되는 하나를 함유하는 진통제.
    상기식에서 =A-B=는 =CH-CH= 또는 -N-CR2=이고, Alk는 탄소수 2 내지 4의 알킬렌 그룹이고, R1는 H, 디알킬아미노알킬, 카복시알킬, 알콕시;카보닐아킬, 카바모일알킬, N-알킬카바모일알킬 또는 N,N-디알킬카바모일알킬이고, Y는 CH 또는 N이고, Z는 결합 또는 -CO-이고, Ar은 비치환 되거나 또는 알킬, 알콕시, F, Cl, Br, II 및/또는 CF3로 한번 이상 치환된 페닐, 티에닐 또는 피리딜 그룹이고, R2는 H, 알킬, 알콕시 또는 알킬티오이며, 상기에서, 알킬, 알콕시 및 알킬티오 그룹은 각기 탄소수 1내지 4를 함유한다.
  2. 일반식(I)의 화합물 및/또는 이의 생리학적으로 허용되는 염중 하나를 적어도 1종의 고체, 액체 및/또는 반액체 비히클 또는 보조제와 함께, 필요에 따라 종이상의 다른 활성 화합물(들)과 조합하여 적합한 투여형태로 전환시키는 것을 특징으로 하는 제1항에 따른 진통제의 제조방법.
  3. 통증을 억제시키기 위한 제1항에 따른 일반식(I)의 화합물 및/또는 이들의 생리학적으로 허용되는 염의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880014833A 1987-11-16 1988-11-11 진통제 KR890007741A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873738844 DE3738844A1 (de) 1987-11-16 1987-11-16 Analgetikum
DEP3738844.4 1987-11-16

Publications (1)

Publication Number Publication Date
KR890007741A true KR890007741A (ko) 1989-07-05

Family

ID=6340578

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880014833A KR890007741A (ko) 1987-11-16 1988-11-11 진통제

Country Status (15)

Country Link
US (1) US4950648A (ko)
EP (1) EP0316668B1 (ko)
JP (1) JPH01160919A (ko)
KR (1) KR890007741A (ko)
AT (1) ATE89481T1 (ko)
AU (1) AU616695B2 (ko)
CA (1) CA1317549C (ko)
DE (2) DE3738844A1 (ko)
ES (1) ES2069541T3 (ko)
GR (1) GR3007918T3 (ko)
HU (1) HU203199B (ko)
IE (1) IE61301B1 (ko)
PH (1) PH25353A (ko)
PT (1) PT89000B (ko)
ZA (1) ZA888574B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
US5095019A (en) * 1990-08-27 1992-03-10 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-D)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US6166019A (en) * 1998-07-16 2000-12-26 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
US7074834B2 (en) * 2000-05-24 2006-07-11 University Of Kentucky Foundation Long acting, reversible veterinary sedative and analgesic and method of use
FR2832711B1 (fr) 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
CA2544245A1 (en) * 2003-10-30 2005-05-26 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843073A (en) * 1958-05-09 1960-08-04 Toraude Lab 2-methyl-3-orthotolyl-4-quinazolone and acid addition salts thereof
FR1043M (fr) * 1960-12-28 1962-02-09 Soc Ind Fab Antibiotiques Sifa Dérivé de la quinazolone et ses sels, utilisés en thérapeutique.
US3919425A (en) * 1971-04-09 1975-11-11 Miles Lab Method of producing vasodilation using certain 3-substituted-quinazoline derivatives
DE2143117A1 (de) * 1971-08-28 1973-03-08 Troponwerke Dinklage & Co Neue 2-methyl-3-geschweifte klammer auf 3- eckige klammer auf 4-phenylpiperazinyl(1) eckige klammer zu -2-hydroxypropyl geschweifte klammer zu chinazolinon-(4)derivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
DE3601731A1 (de) * 1986-01-22 1987-07-23 Merck Patent Gmbh Pyrimidinderivate

Also Published As

Publication number Publication date
ES2069541T3 (es) 1995-05-16
ATE89481T1 (de) 1993-06-15
HU203199B (en) 1991-06-28
DE3881164D1 (de) 1993-06-24
AU616695B2 (en) 1991-11-07
DE3738844A1 (de) 1989-05-24
EP0316668A3 (en) 1990-09-19
ZA888574B (en) 1989-08-30
CA1317549C (en) 1993-05-11
US4950648A (en) 1990-08-21
EP0316668A2 (de) 1989-05-24
PT89000A (pt) 1988-12-01
AU2510788A (en) 1989-05-18
PT89000B (pt) 1993-02-26
IE883417L (en) 1989-05-16
PH25353A (en) 1991-05-13
JPH01160919A (ja) 1989-06-23
GR3007918T3 (ko) 1993-08-31
IE61301B1 (en) 1994-10-19
EP0316668B1 (de) 1993-05-19
HUT48818A (en) 1989-07-28

Similar Documents

Publication Publication Date Title
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
KR890000470A (ko) 2,2-디메틸크로만-3-올 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
KR870700067A (ko) 피리도(2,3-d)-피리미딘 유도체
AT384424B (de) Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
NO301542B1 (no) Nye pyrazin-derivater
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
KR960007592A (ko) 신규한 피롤로카바졸
KR940006580A (ko) 질병을 치료하기 위한 치환된 사이클로헥산 유도체
KR850008342A (ko) N-알케닐-3-히드록시벤조 [b]티오펜-2-카복스아미드 유도체의 제조방법
KR890007741A (ko) 진통제
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
KR890014542A (ko) 4-치환된 피라졸로[3,4-d] 피리미딘 유도체
KR900001715A (ko) Bu-3608 유도체
KR900014397A (ko) 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR890006234A (ko) 고혈압 및 심부전증 치료제
KR890013019A (ko) 과뇨산혈증을 치료하는데 있어서의 옥소퀴나졸린 유도체의 용도
KR900018084A (ko) 티에닐 피페라지논, 이의 제조방법 및 이의 용도
KR870004985A (ko) 2위치에서 4급화한 헤테로티오알킬티오 치환이 있는 카바펜엠
KR840005105A (ko) 의약용 피리다지논류 유도체의 제조방법
KR900007811A (ko) 1-아미노알킬-3옥시치환된-4-아릴-1,3,4,5-테트라하이드로-2h-1.3-벤조디아제핀-2-은, 이의 제조방법 및 이의 약제로서의 용도
NO177707C (no) Fremgangsmåte for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksyd-(1R,2R)
KR890003372A (ko) 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약
KR880009647A (ko) 우울증 치료 활성을 갖는 제제
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
KR870001153A (ko) 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application